Ordentlich Peter's Form 4 filing
Syndax Pharmaceuticals IncSNDX · filed Dec 2, 2022
- Accession no.
- 0001562180-22-008017
- Filed
- Dec 2, 2022
- Trade date
- Dec 1-2, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $625.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ordentlich PeterCIK 0001594274 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | Common Stock | MOption exerciseAcquired | +3,772 | $6.35 | +$23,952.2 | 4,037 | Direct | |
| Dec 1, 2022 | Common Stock | SSaleDisposed | −3,772 | $25.01F2 | −$94,337.72 | 265 | Direct | |
| Dec 1, 2022 | Common Stock | MOption exerciseAcquired | +4,028 | $6.38 | +$25,698.64 | 4,293 | Direct | |
| Dec 1, 2022 | Common Stock | SSaleDisposed | −4,028 | $25.01F2 | −$100,740.28 | 265 | Direct | |
| Dec 2, 2022 | Common Stock | MOption exerciseAcquired | +17,200 | $6.38 | +$109,736 | 17,465 | Direct | |
| Dec 2, 2022 | Common Stock | SSaleDisposed | −17,200 | $25.05F3 | −$430,860 | 265 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | Common Stock | MOption exerciseDisposed | −4,028 | $0.00 | $0 | 0 | Direct | |
| Dec 1, 2022 | Common Stock | MOption exerciseDisposed | −3,772 | $0.00 | $0 | 0 | Direct | |
| Dec 2, 2022 | Common Stock | MOption exerciseDisposed | −17,200 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The sale prices ranged from $25.00 to $25.03.
Referenced by the price of 2 transactions in Table I.
- F3
The sale prices ranged from $25.00 to $25.19.
Referenced by the price of 1 transaction in Table I.